Inventor · disambiguated record
Mirko Zaja
Also filed as: ZAJA MIRKO
8 granted patents·4 pending applications·12 citations·filing 2010–2020
78Inventor score
Files with4SC AG44SC DISCOVERY GMBH3GIJSEN HENRICUS JACOBUS MARIA2BERTHELOT DIDIER JEAN-CALUDE1CELLZOME LTD1
Top patents by PatentIndex Score
12 records- 0175US8614201B2Heterocyclic amides as modulators of TRPA1BERTHELOT DIDIER JEAN-CALUDE·Filed 2010·Granted Dec 24, 2013·6 cites·17 claims
- 0273US10005769B22,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors4SC DISCOVERY GMBH·Filed 2014·Granted Jun 26, 2018·3 cites·39 claims
- 0370US8772504B2Substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulatorsGIJSEN HENRICUS JACOBUS MARIA·Filed 2010·Granted Jul 8, 2014·2 cites·12 claims
- 0467US9580438B2Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders4SC DISCOVERY GMBH·Filed 2013·Granted Feb 28, 2017·1 cites·26 claims
- 0564US2020377514A1Kv1.3 inhibitors and their medical application4SC AG·Filed 2020·Application pending·0 cites
- 0663US10723743B2Kv1.3 inhibitors and their medical application4SC AG·Filed 2019·Granted Jul 28, 2020·0 cites·16 claims
- 0763US2020339592A1Kv1.3 inhibitors and their medical application4SC AG·Filed 2020·Application pending·0 cites
- 0856US10822345B2KV1.3 inhibitors and their medical application4SC AG·Filed 2016·Granted Nov 3, 2020·0 cites·18 claims
- 0952US2015094311A1Novel substituted bicyclic heterocyclic compounds as gamma secretase modulatorsCELLZOME LTD·Filed 2014·Application pending·0 cites
- 1044US2017240556A1Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders4SC DISCOVERY GMBH·Filed 2017·Application pending·0 cites
- 1143US8946426B2Substituted bicyclic heterocyclic compounds as gamma secretase modulatorsGIJSEN HENRICUS JACOBUS MARIA·Filed 2010·Granted Feb 3, 2015·0 cites·9 claims
- 1241US11292788B2IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammationIMMUNIC AG·Filed 2018·Granted Apr 5, 2022·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →